SUBSCRIBE
SUBSCRIBE
News   Drug Development

Medivir AB Files Clinical Trial Application To Start Phase I With MIV-701.

January 4, 2007 | 
1 min read
STOCKHOLM, Sweden--(BUSINESS WIRE)--Medivir (STO:MVIRB) has filed an application with a European regulatory authority to commence phase I clinical trials with MIV-701, an inhibitor of cathepsin K. The trials are expected to start in Q1/2007.
Clinical research Phase 1 Europe
MORE ON THIS TOPIC
Lung organ anatomy symbol for health and medical illustrations. vector, illustration.
Antibody-drug conjugate (ADC)
Kelun-Merck validate TROP2-Keytruda pairing in lung cancer with improved survival
May 22, 2026
 · 
3 min read
 · 
Annalee Armstrong
Electricity saving, ecology awareness or reduce electric cost and expense concept, man pulling electric cord to unplug to save money or for ecology power.
Parkinson’s disease
Biogen, Denali pull plug on Parkinson’s program after mid-stage flop
May 22, 2026
 · 
2 min read
 · 
Tristan Manalac
Human liver organ and pills. World hepatitis day. National liver health awareness month. Liver transplantation, donation background. Save patient life in hospital with liver transplant
Postmarket research
Update: Reversal after 20 deaths allows new Japan patients to take Amgen’s rare disease drug Tavneos
May 21, 2026
 · 
3 min read
 · 
Tristan Manalac
Crowd silhouettes reach toward a raised trophy beneath a vivid sunset sky, showing shared ambition, victory, teamwork, celebration, and success with open space for text.
Weight loss
Lilly’s triple agonist shows bariatric surgery–like weight loss results
May 21, 2026
 · 
3 min read
 · 
Annalee Armstrong